Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ease Labs is a Brazilian pharmaceutical company specializing in the development, manufacturing, and distribution of cannabis-derived medicinal products. The company operates a state-of-the-art GMP-certified facility in Belo Horizonte, where it produces standardized cannabinoid formulations including CBD isolates and full-spectrum extracts. Ease Labs was one of the first companies to receive sanitary authorization from ANVISA under the RDC 327/2019 regulation to commercialize cannabis products in Brazilian pharmacies. Their business model integrates a vertically aligned supply chain with a strong emphasis on clinical evidence and medical education to support treatments for neurological and psychiatric conditions. The company is recognized as a leader in the Latin American medical cannabis sector, focusing on pharmaceutical-grade quality and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ease Labs Pharma.